Match!
Vadim Gushchin
Mercy Medical Center (Baltimore, Maryland)
58Publications
14H-index
866Citations
Publications 58
Newest
#1Katherin Zambrano-Vera (Mercy Medical Center (Baltimore, Maryland))H-Index: 1
#2Armando Sardi (Mercy Medical Center (Baltimore, Maryland))H-Index: 25
Last.Vadim Gushchin (Mercy Medical Center (Baltimore, Maryland))H-Index: 14
view all 9 authors...
Background Appendiceal goblet cell adenocarcinoma (GCA) is often misclassified and mistreated due to mixed histologic features. In general, cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is standard of care for peritoneal carcinomatosis (PC) from mucinous appendiceal tumors; however, in PC from GCA, data are limited and the role of CRS/HIPEC is controversial. We report outcomes in PC from appendiceal GCA treated with CRS/HIPEC.
1 CitationsSource
#1Carlos Munoz-Zuluaga (Mercy Medical Center (Baltimore, Maryland))H-Index: 1
#2Mary Caitlin King (Mercy Medical Center (Baltimore, Maryland))H-Index: 1
Last.Armando Sardi (Mercy Medical Center (Baltimore, Maryland))H-Index: 25
view all 8 authors...
Abstract Background The role of systemic chemotherapy (SC) before cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) in appendiceal high-grade mucinous carcinoma peritonei (HGMCP) is controversial. We analyzed the effect of SC prior to CRS/HIPEC in HGMCP. Methods A prospective database of CRS/HIPEC procedures for HGMCP without signet ring cells and with signet ring cells (HGMCP-S) from 1998 to 2017 was reviewed. Exclusion criteria was prior surgery >5 regions or >2 r...
Source
#1Carlos Munoz-Zuluaga (Mercy Medical Center (Baltimore, Maryland))H-Index: 1
#2Mary Caitlin King (Mercy Medical Center (Baltimore, Maryland))H-Index: 1
Last.Vadim Gushchin (Mercy Medical Center (Baltimore, Maryland))H-Index: 14
view all 8 authors...
Background Survival in peritoneal dissemination from appendiceal cancer after complete cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) varies within each histopathologic subtype. Analyzing patients with unique responses may uncover the mechanisms behind their extreme outcomes. We proposed a method to identify retrospectively and to characterize patients who responded exceptionally well or very poorly within each histopathologic subtype.
1 CitationsSource
Source
Source
10512Background: Disparities in current global oncology care are a major concern for many societies. Two-year oncological training in Russia is deficient in evidence-based medicine (EBM) and effect...
#1Carlos Munoz-Zuluaga (Mercy Medical Center (Baltimore, Maryland))H-Index: 1
#2Armando Sardi (Mercy Medical Center (Baltimore, Maryland))H-Index: 25
Last.Vadim Gushchin (Mercy Medical Center (Baltimore, Maryland))H-Index: 14
view all 7 authors...
Background Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC) is standard treatment for peritoneal dissemination from appendiceal cancer (AC); however, its role in high-grade histopathologic subtypes (high-grade mucinous carcinoma peritonei [HGMCP] and HGMCP with signet ring cells [HGMCP-S]) is controversial due to their aggressive behavior. This study analyzed clinical outcomes of high-grade AC after CRS/HIPEC.
1 CitationsSource
#1Arkadii Sipok (Mercy Medical Center (Baltimore, Maryland))H-Index: 1
#2Armando Sardi (Mercy Medical Center (Baltimore, Maryland))H-Index: 25
Last.Vadim Gushchin (Mercy Medical Center (Baltimore, Maryland))H-Index: 14
view all 6 authors...
Background. The role of hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis (PC) from colorectal cancer (CRC) is debated. Melphalan as a perfusion agent has also demonstrated survival benefit in other recurrent and chemoresistant malignancies. Thus, we hypothesize that melphalan as a HIPEC agent may improve overall survival (OS) and progression-free survival (PFS) in patients with PC from CRC. Methods. A retrospective review of a prospective database of 48 patients wh...
Source
#1Sanket Mehta (Saifee Hospital)H-Index: 5
#2Lilian SchwarzH-Index: 14
Last.F. ZinzindohoueH-Index: 4
view all 86 authors...
Abstract Introduction Peritoneal metastasis (PM) of hepatocellular carcinoma (HCC) without distant spread are rare. The related prognosis is poor without standard treatment available. The role of cytoreduction surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) is poorly documented. Methods An international multicentric cohort was constituted by retrospective analysis of 21 patients undergoing CRS/HIPEC for PM of HCC between 1992 and 2016 from 10 reference centers of PSOGI. Data ...
3 CitationsSource
#1Barchuk Aa (UTA: University of Tampere)H-Index: 2
#2Vadim GushchinH-Index: 14
Source
123456